GBM also elicits an adaptive immune response and there is an increased infiltrate of CD4+FoxP3+ regulatory T cells in GBM relative to lower-grade gliomas and normal brain [20], [22], [23]. This evidence concerns the gene CD4 and central nervous system cancer.